University of Ottawa, Ottawa, Ontario, Canada.
Dermatitis. 2012 Nov-Dec;23(6):288-90. doi: 10.1097/DER.0b013e318277ca22.
Both immediate, type I reactions and delayed hypersensitivity, type IV reactions to systemic corticosteroid preparations have been reported. Type I reactions are rare, with delayed hypersensitivity reactions being slightly more common.
A 33-year-old woman presented repeatedly to the emergency department with asthma attacks. She developed pruritus and hives approximately 30 minutes after the administration of parenteral corticosteroids. Her respiratory status deteriorated approximately 6 hours after she received the corticosteroids. An acute eczematous dermatitis on her face, neck, and upper body appeared 24 hours after administration of the corticosteroids. The dermatitis peaked at 72 hours. Intradermal testing to Solu-Medrol, Solu-Cortef, prednisone, and Decadron confirmed a type I, anaphylactoid reaction. The dermatitis that presented 24 hours after administration of the parenteral corticosteroids is consistent clinically with a type IV delayed hypersensitivity reaction to the corticosteroids. A second patient, a 51-year-old woman, developed urticarial lesions that lasted approximately 30 minutes, immediately after intralesional triamcinolone injections for keloid scars. Intradermal testing was performed. She showed a positive reaction to triamcinolone confirming a type I allergy to this steroid.
It is important to consider an allergy to corticosteroids in patients with worsening anaphylactic symptoms after administration of systemic corticosteroids.
全身性皮质类固醇制剂可引起即刻 I 型反应和迟发性超敏反应(IV 型反应)。I 型反应罕见,迟发性超敏反应略多见。
一名 33 岁女性因哮喘发作多次到急诊科就诊。她在接受皮质类固醇静脉注射后约 30 分钟出现瘙痒和荨麻疹。大约在她接受皮质类固醇治疗 6 小时后,她的呼吸状况恶化。在接受皮质类固醇治疗 24 小时后,她的面部、颈部和上半身出现急性湿疹性皮炎。72 小时时皮疹达到高峰。对 Solu-Medrol、Solu-Cortef、泼尼松和地塞米松进行皮内试验,证实为 I 型、过敏样反应。在接受皮质类固醇静脉注射 24 小时后出现的皮疹在临床上与对皮质类固醇的 IV 型迟发性超敏反应一致。第二位患者为 51 岁女性,在接受瘢痕内曲安奈德注射治疗瘢痕疙瘩后约 30 分钟出现荨麻疹样皮损。进行皮内试验。她对曲安奈德呈阳性反应,证实对这种类固醇过敏。
对于接受全身性皮质类固醇治疗后出现过敏症状加重的患者,应考虑皮质类固醇过敏。